87.77
price down icon0.69%   -0.61
after-market アフターアワーズ: 87.78 0.01 +0.01%
loading
前日終値:
$88.38
開ける:
$88.6
24時間の取引高:
8.52M
Relative Volume:
0.72
時価総額:
$152.88B
収益:
$45.13B
当期純損益:
$6.28B
株価収益率:
24.45
EPS:
3.5895
ネットキャッシュフロー:
$7.38B
1週間 パフォーマンス:
+3.38%
1か月 パフォーマンス:
-5.34%
6か月 パフォーマンス:
-31.49%
1年 パフォーマンス:
-34.03%
1日の値動き範囲:
Value
$86.83
$88.60
1週間の範囲:
Value
$84.13
$89.34
52週間の値動き範囲:
Value
$81.97
$139.06

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1106)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-04-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
87.77 153.94B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
313.50 123.25B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
78.15 100.34B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
57.15 84.23B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
83.20 47.77B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-22 ダウングレード Daiwa Securities Outperform → Neutral
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
06:00 AM

​Buying pulsed field ablation systems: What hospitals should know - Modern Healthcare News

06:00 AM
pulisher
03:37 AM

Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence - GlobeNewswire Inc.

03:37 AM
pulisher
May 20, 2026

Abbott Laboratories stock (US0028241000): diabetes business and latest earnings in focus - AD HOC NEWS

May 20, 2026
pulisher
May 20, 2026

Abbott Laboratories stock (US0028241000): investors eye upcoming Q4 2025 earnings call and biosimila - AD HOC NEWS

May 20, 2026
pulisher
May 20, 2026

Better medical device stock right now: Abbott Laboratories vs. Dexcom - MSN

May 20, 2026
pulisher
May 20, 2026

Abbott Laboratories cuts outlook, says mild flu season hurt sales - MSN

May 20, 2026
pulisher
May 20, 2026

Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum - TradingView

May 20, 2026
pulisher
May 20, 2026

Abbott Laboratories stock (US0028241000): steady medical devices player after latest quarterly updat - AD HOC NEWS

May 20, 2026
pulisher
May 20, 2026

Worker says Abbott fired him over a chat his coworker started - hcamag.com

May 20, 2026
pulisher
May 19, 2026

ECMC debuts new high-tech blood & urine lab to cut down on processing times by 20 percent - WKBW

May 19, 2026
pulisher
May 19, 2026

Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch

May 19, 2026
pulisher
May 19, 2026

Abbott Spinal Cord Stimulator Problems Resulted in Severe Paralysis: Lawsuit - AboutLawsuits.com

May 19, 2026
pulisher
May 19, 2026

Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $109 - 富途牛牛

May 19, 2026
pulisher
May 19, 2026

Abbott Laboratories Insiders Added US$4.23m Of Stock To Their Holdings - Yahoo Finance

May 19, 2026
pulisher
May 19, 2026

Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS

May 19, 2026
pulisher
May 19, 2026

Has The Recent Slide In Abbott Laboratories (ABT) Opened Up A Valuation Opportunity? - simplywall.st

May 19, 2026
pulisher
May 19, 2026

Build-A-Bear Workshop and Abbott Laboratories o... | Pluang – Crypto, Stocks, Gold & Funds - Pluang

May 19, 2026
pulisher
May 18, 2026

A Look at Abbott Laboratories (ABT) After 4.1% Gain -- GF Value $127.69 vs Price $87.91 - GuruFocus

May 18, 2026
pulisher
May 18, 2026

Has the Abbott Laboratories sell-off finally created an entry point? - MSN

May 18, 2026
pulisher
May 18, 2026

Abbott Laboratories Stock (ABT) Moved Up by 3.04% on May 18: What Investors Need To Know - TradingKey

May 18, 2026
pulisher
May 18, 2026

Boston Scientific Bets on Growth Through Strategic M&A Deals - TradingView

May 18, 2026
pulisher
May 18, 2026

Raised full-year 2026 outlook lifts Abbott stock 3.18% - Traders Union

May 18, 2026
pulisher
May 18, 2026

Abbott Laboratories (ABT) is attracting investor attention: Here is what you should know - MSN

May 18, 2026
pulisher
May 18, 2026

Trump’s stock trading spree included North Chicago’s Abbott Labs - Crain's Chicago Business

May 18, 2026
pulisher
May 18, 2026

Abbott stock posts modest gain amid fragile momentum below MA-20 resistance: weekly review - Traders Union

May 18, 2026
pulisher
May 18, 2026

ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now? - TradingView

May 18, 2026
pulisher
May 18, 2026

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 18, 2026
pulisher
May 18, 2026

Thrivent Financial for Lutherans Acquires 48,286 Shares of Abbott Laboratories $ABT - MarketBeat

May 18, 2026
pulisher
May 18, 2026

North Dakota State Investment Board Purchases New Stake in Abbott Laboratories $ABT - MarketBeat

May 18, 2026
pulisher
May 18, 2026

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 40% Potential Upside for Savvy Investors - DirectorsTalk Interviews

May 18, 2026
pulisher
May 18, 2026

Abbott Laboratories $ABT Shares Purchased by Cambridge Investment Research Advisors Inc. - MarketBeat

May 18, 2026
pulisher
May 18, 2026

Abbott Laboratories stock (US0028241000): Q1 2026 growth, guidance raise and diabetes momentum - AD HOC NEWS

May 18, 2026
pulisher
May 17, 2026

Abbott Laboratories stock (US0028241000): diabetes growth and fresh guidance keep investors focused - AD HOC NEWS

May 17, 2026
pulisher
May 17, 2026

Abbott Laboratories Stock (ABT) Opinions on Recent Price Declines - Quiver Quantitative

May 17, 2026
pulisher
May 17, 2026

Abbott Laboratories stock (US0028241000): diabetes segment drives attention after latest quarterly u - AD HOC NEWS

May 17, 2026
pulisher
May 17, 2026

Abbott Laboratories $ABT Stock Holdings Lowered by iA Global Asset Management Inc. - MarketBeat

May 17, 2026
pulisher
May 17, 2026

AlphaCore Capital LLC Increases Stock Position in Abbott Laboratories $ABT - MarketBeat

May 17, 2026
pulisher
May 17, 2026

Abacus Wealth Partners LLC Buys 12,260 Shares of Abbott Laboratories $ABT - MarketBeat

May 17, 2026
pulisher
May 16, 2026

Abbott Laboratories Trade Ideas — LSX:850103 - TradingView

May 16, 2026
pulisher
May 16, 2026

Assessing Abbott Laboratories (ABT) Valuation After Nutrition Setbacks Legal Uncertainty And Softer Analyst Sentiment - simplywall.st

May 16, 2026
pulisher
May 16, 2026

Commerzbank Aktiengesellschaft FI Sells 131,572 Shares of Abbott Laboratories $ABT - MarketBeat

May 16, 2026
pulisher
May 16, 2026

Bessemer Group Inc. Sells 213,665 Shares of Abbott Laboratories $ABT - MarketBeat

May 16, 2026
pulisher
May 15, 2026

ABT (NYSE: ABT) Form 144 shows 7,587 RSU shares and prior 29,211 sale - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Is Abbott’s Exact Sciences Deal And Nutrition Pivot Altering The Investment Case For Abbott (ABT)? - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Abbott Laboratories slammed on its post-Exact Sciences guidance - MSN

May 15, 2026
pulisher
May 15, 2026

Is the options market predicting a spike in Abbott Laboratories stock? - MSN

May 15, 2026
pulisher
May 15, 2026

Abbott Laboratories stock (US0028241000): Q1 beat, Exact Sciences deal and legal risks keep investor - AD HOC NEWS

May 15, 2026
pulisher
May 15, 2026

Abbott class action alleges FreeStyle Libre 2 glucose monitor is defective - Class Action Lawsuits

May 15, 2026
pulisher
May 15, 2026

How Abbott's Volume-Driven Nutrition Strategy Is Shaping Up - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Phoenix Financial Ltd. Increases Stock Position in Abbott Laboratories $ABT - MarketBeat

May 15, 2026
pulisher
May 15, 2026

Summit Wealth Group LLC Co. Sells 21,449 Shares of Abbott Laboratories $ABT - MarketBeat

May 15, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Abbott Laboratories (ABT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
STARKS DANIEL J
Director
Apr 27 '26
Buy
92.65
10,000
926,537
6,751,103
SYK SYK
$313.50
price down icon 2.49%
MDT MDT
$78.15
price up icon 0.00%
BSX BSX
$57.15
price up icon 0.85%
EW EW
$83.20
price up icon 0.28%
$64.33
price up icon 0.11%
大文字化:     |  ボリューム (24 時間):